You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
Merck
AstraZeneca
Medtronic

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Pentobarbital sodium - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for pentobarbital sodium and what is the scope of freedom to operate?

Pentobarbital sodium is the generic ingredient in four branded drugs marketed by Oak Pharms, Lannett, Vitarine, Whiteworth Town Plsn, Anabolic, Elkins Sinn, Everylife, Halsey, Ivax Sub Teva Pharms, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Watson Labs, Wyeth Ayerst, Athenex, Custopharm Inc, Sagent Pharms Inc, and Nexgen Pharma Inc, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentobarbital sodium. Four suppliers are listed for this compound.

Summary for pentobarbital sodium

US Patents and Regulatory Information for pentobarbital sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett PENTOBARBITAL SODIUM pentobarbital sodium CAPSULE;ORAL 085915-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 206404-001 May 23, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Nexgen Pharma Inc SODIUM PENTOBARBITAL pentobarbital sodium TABLET;ORAL 084238-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
Merck
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.